Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06644404
PHASE1

Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults

Sponsor: Daewoong Pharmaceutical Co. LTD.

View on ClinicalTrials.gov

Summary

This study aims to evaluate the pharmacokinetic/pharmacodynamic drug-drug interactions between DWP16001, DWC202407, and DWC202408 in healthy adults

Official title: A Randomized, Open, Two-sequence, Crossover, Multiple Oral Administrations, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Drug-drug Interaction Between DWP16001, DWC202407, and DWC202408 in Healthy Adults

Key Details

Gender

All

Age Range

19 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

34

Start Date

2024-10-26

Completion Date

2025-04-01

Last Updated

2024-10-16

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

DWP16001 0.3mg

1 tablet, Orally, Once daily single dose

DRUG

DWC202407 1,000mg

1 tablet, Orally, Twice daily

DRUG

DWC202408 2mg

1 tablet, Orally, Once daily single dose

Locations (1)

Seoul National University Hospital

Seoul, South Korea